CAS 934493-76-2
:N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide
Description:
N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide, with CAS number 934493-76-2, is a synthetic organic compound characterized by its complex molecular structure, which includes multiple aromatic rings and functional groups such as amines, sulfonamides, and methoxy groups. This compound is typically studied for its potential biological activity, particularly in the field of medicinal chemistry, where it may exhibit properties relevant to drug development. The presence of the quinoxaline moiety suggests potential interactions with biological targets, possibly influencing pathways related to cancer or other diseases. Its solubility, stability, and reactivity can vary based on the specific conditions, such as pH and solvent, which are crucial for its application in research or therapeutic contexts. As with many synthetic compounds, safety data, including toxicity and handling precautions, should be reviewed before use in laboratory settings. Overall, this compound represents a class of molecules that may hold promise for further investigation in pharmacological studies.
Formula:C31H29N5O6S
Synonyms:- Xl765
- Xl-765
- Sar245409
- Voxtalisib
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
CAS:Formula:C13H14N6OPurity:99%Color and Shape:SolidMolecular weight:270.28992-Amino-8-Ethyl-4-Methyl-6-(1H-Pyrazol-3-Yl)Pyrido[2,3-D]Pyrimidin-7(8H)-One
CAS:2-Amino-8-Ethyl-4-Methyl-6-(1H-Pyrazol-3-Yl)Pyrido[2,3-D]Pyrimidin-7(8H)-OnePurity:98%Molecular weight:270.29g/molVoxtalisib
CAS:<p>Voxtalisib (XL765) (SAR245409, XL765) is a dual inhibitor of mTOR/PI3K, mostly for p110γ with IC50 of 9 nM; also inhibits DNA-PK and mTOR. Phase 1/2.</p>Formula:C13H14N6OPurity:98.21% - 99.69%Color and Shape:SolidMolecular weight:270.29


